{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:07:27Z","timestamp":1793815647542,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.eclinm.2024.102567","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T15:42:14Z","timestamp":1712850134000},"page":"102567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5890-2953","authenticated-orcid":false,"given":"Neil","family":"Marlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Lepore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair R.","family":"Fielder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Weisberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Lodha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.eclinm.2024.102567_bib1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.18240\/ijo.2021.08.17","article-title":"Survey of current retinopathy of prematurity practices in China","volume":"14","author":"Le","year":"2021","journal-title":"Int J Ophthalmol"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102567_bib2","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.4103\/ijo.IJO_200_21","article-title":"Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: a survey among the members of Indian Retinopathy of Prematurity Society","volume":"69","author":"Gangwe","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.eclinm.2024.102567_bib3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2147\/OPTH.S161504","article-title":"Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists","volume":"12","author":"Fouzdar","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102567_bib4","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.ophtha.2022.06.008","article-title":"Retinopathy of prematurity treatment trends from 2003 to 2020 in the United States","volume":"129","author":"Khan","year":"2022","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102567_bib5","first-page":"61","article-title":"Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity","volume":"22","author":"Kennedy","year":"2018","journal-title":"J\u00a0AAPOS"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102567_bib6","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0057","article-title":"Concerns for development after bevacizumab treatment of ROP","volume":"137","author":"Quinn","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102567_bib7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102567_bib8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3537","article-title":"Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment","volume":"144","author":"Natarajan","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102567_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230678","article-title":"Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity","volume":"15","author":"Arima","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102567_bib10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41372-020-00884-9","article-title":"Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis","volume":"41","author":"Kaushal","year":"2021","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.eclinm.2024.102567_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1055813","article-title":"Retinopathy of prematurity and neurodevelopmental outcomes in preterm infants: a systematic review and meta-analysis","volume":"11","author":"Diggikar","year":"2023","journal-title":"Front Pediatr"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102567_bib12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10792-022-02480-6","article-title":"Comparison of adverse events between intravitreal anti-VEGF and laser photocoagulation for treatment-requiring retinopathy of prematurity: a systematic review","volume":"43","author":"Tsiropoulos","year":"2023","journal-title":"Int Ophthalmol"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102567_bib13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2352-4642(21)00195-4","article-title":"2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial","volume":"5","author":"Marlow","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102567_bib14","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","article-title":"Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial","volume":"132","author":"Geloneck","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"10208","key":"10.1016\/j.eclinm.2024.102567_bib15","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102567_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41390-019-0526-1","article-title":"Assessment of long-term neurodevelopmental outcome following trials of medicinal products in newborn infants","volume":"86","author":"Marlow","year":"2019","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102567_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12886-016-0386-y","article-title":"Assessment of near visual acuity in 0-13 year olds with normal and low vision: a systematic review","volume":"16","author":"Huurneman","year":"2016","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102567_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00006324-199206000-00003","article-title":"The Cardiff Test: a new visual acuity test for toddlers and children with intellectual impairment. A preliminary report","volume":"69","author":"Adoh","year":"1992","journal-title":"Optom Vis Sci"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102567_bib20","first-page":"473","article-title":"Validity and reliability of the children's visual function questionnaire (CVFQ)","volume":"11","author":"Birch","year":"2007","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.eclinm.2024.102567_bib21","series-title":"Mullen scales of early learning","author":"Mullen","year":"1995"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102567_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1469-8749.1997.tb07414.x","article-title":"Development and reliability of a system to classify gross motor function in children with cerebral palsy","volume":"39","author":"Palisano","year":"1997","journal-title":"Dev Med Child Neurol"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102567_bib23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/ptj\/80.10.974","article-title":"Validation of a model of gross motor function for children with cerebral palsy","volume":"80","author":"Palisano","year":"2000","journal-title":"Phys Ther"},{"key":"10.1016\/j.eclinm.2024.102567_bib24","series-title":"European public assessment report","year":"2023"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102567_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jamapediatrics.2017.4838","article-title":"Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial","volume":"172","author":"Stahl","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102567_bib26","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1111\/aos.14852","article-title":"Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study","volume":"100","author":"Stahl","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102567_bib27","first-page":"1","article-title":"Bevacizumab for retinopathy of prematurity and neurodevelopment","volume":"27","author":"Binenbaum","year":"2023","journal-title":"J\u00a0AAPOS"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102567_bib28","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/bjophthalmol-2014-305252","article-title":"Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD","volume":"98","author":"Avery","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102567_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1167\/tvst.9.8.43","article-title":"Ranibizumab population pharmacokinetics and free VEGF pharmacodynamics in preterm infants with retinopathy of prematurity in the RAINBOW trial","volume":"9","author":"Fidler","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102567_bib30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(02)01825-1","article-title":"A\u00a0computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol","volume":"135","author":"Beck","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102567_bib31","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ophtha.2009.01.019","article-title":"Normative monocular visual acuity for early treatment diabetic retinopathy study charts in emmetropic children 5 to 12 years of age","volume":"116","author":"Dobson","year":"2009","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102567_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clp.2013.02.008","article-title":"Outcome of retinopathy of prematurity","volume":"40","author":"Holmstr\u00f6m","year":"2013","journal-title":"Clin Perinatol"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102567_bib33","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/archophthalmol.2012.2118","article-title":"Correlation of recognition visual acuity with posterior retinal structure in advanced retinopathy of prematurity","volume":"130","author":"Wallace","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102567_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3928\/23258160-20200228-07","article-title":"Functional and morphologic findings at four years after intravitreal bevacizumab or laser for type 1 ROP","volume":"51","author":"Lepore","year":"2020","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102567_bib35","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ophtha.2017.09.020","article-title":"Foveal development in infants treated with bevacizumab or laser photocoagulation for retinopathy of prematurity","volume":"125","author":"Vogel","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2024.102567_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.spen.2019.05.005","article-title":"Cerebral\/cortical visual impairment: a need to reassess current definitions of visual impairment and blindness","volume":"31","author":"Kran","year":"2019","journal-title":"Semin Pediatr Neurol"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102567_bib37","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International classification of retinopathy of prematurity, third edition","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102567_bib38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2017.08.005","article-title":"Follow-up to age 4 Years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings","volume":"125","author":"Lepore","year":"2018","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102567_bib39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1542\/peds.109.1.12","article-title":"Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity","volume":"109","author":"O'Connor","year":"2002","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102567_bib40","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archopht.121.10.1430","article-title":"A\u00a0population-based study of the refractive outcome in 10-year-old preterm and full-term children","volume":"121","author":"Larsson","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102567_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0161-6420(00)00527-3","article-title":"Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial","volume":"108","author":"Quinn","year":"2001","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102567_bib42","first-page":"124","article-title":"Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age","volume":"17","author":"Quinn","year":"2013","journal-title":"J\u00a0AAPOS"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102567_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042384","article-title":"Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis","volume":"11","author":"Kong","year":"2021","journal-title":"BMJ Open"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T21:52:11Z","timestamp":1760737931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024001469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":42,"alternative-id":["S2589537024001469"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102567","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102567"}}